Matthew A. Bucklin

Matthew A. Bucklin is an associate at Rakoczy Molino Mazzochi Siwik LLP.

Litigation

Mr. Bucklin’s practice focuses on intellectual property litigation, with emphasis on patent infringement suits arising under the Hatch-Waxman Amendments to the Food, Drug and Cosmetic Act and Biologics Price Competition and Innovation Act (BPCIA).

Mr. Bucklin has experience with respect to a wide range of pharmaceutical technologies, including biosimilars, pharmaceutical formulations, and analytical processes.

Previous Experience

Prior to joining Rakoczy Molino Mazzochi Siwik LLP as an Associate, Mr. Bucklin served as a contracting officer at the University of North Carolina and as a contract specialist at Thermo Fisher Scientific, Inc., where he managed legal contract drafting and negotiation. He also gained substantial technical laboratory experience in the biotechnology sector as a scientist at LigaTrap Technologies and as a clinical microbiologist at Genova Diagnostics.

Mr. Bucklin was also an undergraduate researcher in microbiology at North Carolina State University where he won first place at the 16th annual undergraduate research symposium for his research titled “Evaluating plasmid localization in Mycobacterium sp. ELW1 of genes for catabolism of gasoline oxygenate isobutylene.”

During law school, Mr. Bucklin was a staff member of the North Carolina Journal of International Law, where he published his article titled “The Metaverse Can Sustain Legal States.” He also competed as a member of the Holderness Moot Court Negotiations Team and participated